Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Gollob

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|October 31, 1996
CD2-CD58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunityJ A Gollob, J Ritz
European Journal of Immunology|March 1, 1997
Interferon-gamma and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expressionJ A Gollob, H Kawasaki, J Ritz
Experimental Hematology|February 13, 2001
CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cellsS Mahajan, J A Gollob, J Ritz, et al.
The Journal of Experimental Medicine|September 1, 1995
CD2 regulates responsiveness of activated T cells to interleukin 12J A Gollob, J Li, E L Reinherz, et al.
Urology|December 18, 2001
Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol/carboplatin and surgeryJ A Gollob, M P Upton, W C DeWolf, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12J A Gollob, K G Veenstra, J W Mier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylationJ A Gollob, C P Schnipper, E A Murphy, et al.
Blood|March 7, 1998
Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1J A Gollob, E A Murphy, S Mahajan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1996
Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12J A Gollob, J Li, H Kawasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical responseJ A Gollob, J W Mier, K Veenstra, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|October 31, 1996
CD2-CD58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunityJ A Gollob, J Ritz
European Journal of Immunology|March 1, 1997
Interferon-gamma and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expressionJ A Gollob, H Kawasaki, J Ritz
Experimental Hematology|February 13, 2001
CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cellsS Mahajan, J A Gollob, J Ritz, et al.
The Journal of Experimental Medicine|September 1, 1995
CD2 regulates responsiveness of activated T cells to interleukin 12J A Gollob, J Li, E L Reinherz, et al.
Urology|December 18, 2001
Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol/carboplatin and surgeryJ A Gollob, M P Upton, W C DeWolf, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12J A Gollob, K G Veenstra, J W Mier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylationJ A Gollob, C P Schnipper, E A Murphy, et al.
Blood|March 7, 1998
Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1J A Gollob, E A Murphy, S Mahajan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1996
Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12J A Gollob, J Li, H Kawasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical responseJ A Gollob, J W Mier, K Veenstra, et al.
Pageof 2